Queensland Puberty Blocker Ban for Transgender Youth Overturned by Court

Australia’s first state-level ban on puberty blockers for young transgender patients has been overturned by the Queensland Supreme Court today, marking a significant victory for advocates and families.

Justice Peter Callaghan allowed an application for judicial review of the ban, finding that health service executives were given insufficient time – 22 minutes – to consider the directive that halted hormone therapy for young Queenslanders. The legal challenge was initiated by the mother of a transgender teenager who was denied access to treatment following the ban’s implementation in January. The LGBTI Legal Service argued the decision lacked proper public consultation and was not made independently by Queensland Health.

Lawyers representing the mother contended that Queensland Health’s director-general, David Rosengren, improperly exercised his power and that the decision was influenced by the conservative Liberal National Party (LNP) government. Barrister Mark Steele argued there was “clear and direct interference” by the LNP. Justice Callaghan stated, “The only way that was argued that (the Queensland Health CEO) complied with this requirement is by reason of a videoconference which lasted for about 22 minutes.” This ruling comes as debate continues globally regarding the appropriate medical care for transgender youth; the World Health Organization offers guidance on this complex topic.

The overturning of the ban does not establish the medical merits of puberty blockers, but it does mean new patients under 18 can once again access hormone therapies while the government awaits the results of its ongoing review into the treatment. The matter was adjourned today for submissions on costs and final orders.